| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_DLGAP4_0005400 | Exon-Exon | chr20:35127991-35154409 | chr20:36499588-36526006 | 750 nt | 0.5947 |
| hsa_DLGAP4_0005700 | Exon-Exon | chr20:35128602-35154409 | chr20:36500199-36526006 | 661 nt | 0.5976 |
| hsa_RP5-977B1.7_0000100 | Intergenic-Exon | chr20:35128841-35154361 | chr20:36500438-36525958 | 374 nt | 0.5856 |
| hsa_RP5-977B1.7_0000200 | Intergenic-Exon | chr20:35128860-35154361 | chr20:36500457-36525958 | 355 nt | 0.5775 |
| hsa_RP5-977B1.7_0000300 | Intergenic-Intron | chr20:35131359-35137525 | chr20:36502956-36509122 | 250 nt | 0.2880 |
| hsa_RP5-977B1.7_0000400 | Intergenic-Exon | chr20:35134220-35136677 | chr20:36505817-36508274 | 2458 nt | 0.4459 |
| hsa_RP5-977B1.7_0000500 | Intergenic-Exon | chr20:35134220-35141128 | chr20:36505817-36512725 | 250 nt | 0.4200 |
| hsa_RP5-977B1.7_0000600 | Intron-Exon | chr20:35136871-35139420 | chr20:36508468-36511017 | 138 nt | 0.3333 |
| hsa_RP5-977B1.7_0000700 | Intron-Exon-Intron | chr20:35137062-35153112 | chr20:36508659-36524709 | 250 nt | 0.4520 |
| hsa_RP5-977B1.7_0000800 | Intron-Exon-Intron | chr20:35137581-35149471 | chr20:36509178-36521068 | 250 nt | 0.3600 |
A study in mice and humans demonstrated that the circDLGAP4 is significantly decreased in plasma after acute ischemic stroke and in a mouse stroke model, suggesting its potential as a therapeutic target for myocardial ischemia/reperfusion injury [Tian et al. DOI:10.3390/molecules26041155].